Suchergebnisse - "Kong, Ziren"

PubPharm (79)

1

Correction to : A bis-boron boramino acid PET tracer for brain tumor diagnosis

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Li, Z. | Chen, J. | Kong, Z. | +8

ErratumFor: Eur J Nucl Med Mol Imaging. 2024 Jan 9;:. - PMID 38191817

2

A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors

enthalten in: EJNMMI research | 2024

von Kong, Z. | Li, Z. | Chen, J. | +6

3

A bis-boron boramino acid PET tracer for brain tumor diagnosis

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Li, Z. | Chen, J. | Kong, Z. | +8

ErratumIn: Eur J Nucl Med Mol Imaging. 2024 Mar 22;:. - PMID 38517519

4

CT-based quantification of trachea shape to detect invasion by thyroid cancer

enthalten in: European radiology | 2023

von Kong, Z. | Wang, J. | Ni, S. | +5

5

Kruppel-like factor 13 acts as a tumor suppressor in thyroid carcinoma by downregulating IFIT1

enthalten in: Biology direct | 2023

von Liu, Y. | Song, Y. | He, Y. | +4

6

The role of multifocality in predicting central lymph node metastasis in initially treated 18-55 years old female patients with unilateral papillary thyroid microcarcinoma

enthalten in: Frontiers in oncology | 2023

von Zhao, L. | Li, H. | He, Y. | +7

7

Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging

enthalten in: BMC neuroscience | 2022

von Liu, S. | Zhang, Y. | Kong, Z. | +6

8

Prognostic Value of Choline and Other Metabolites Measured Using 1H-Magnetic Resonance Spectroscopy in Gliomas : A Meta-Analysis and Systemic Review

enthalten in: Metabolites | 2022

von Shi, Y. | Liu, D. | Kong, Z. | +5

9

Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging

enthalten in: BMC neuroscience | 2022

von Liu, S. | Zhang, Y. | Kong, Z. | +6

10

86Y-Labeled Albumin-Binding Fibroblast Activation Protein Inhibitor for Late-Time-Point Cancer Diagnosis

enthalten in: Molecular pharmaceutics | 2022

von Ding, J. | Xu, M. | Chen, J. | +4

1
2
3
4
5
6
7
8
Nächster »
[8]